Grandeur Peak Global Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-72,243
Closed -$5.21M 117
2022
Q1
$5.21M Buy
72,243
+37,749
+109% +$2.72M 0.25% 70
2021
Q4
$3.17M Buy
34,494
+7,160
+26% +$856K 0.14% 81
2021
Q3
$3.47M Buy
27,334
+4,100
+18% +$597K 0.16% 80
2021
Q2
$3.86M Buy
+23,234
New +$3.76M 0.18% 73

Other funds holding TDOC

Grandeur Peak Global Advisors's TDOC Position: Q2 2022 in Review

Grandeur Peak Global Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 72,243 shares — an estimated $5.21M sold.

Grandeur Peak Global Advisors first reported a position in TDOC in Q2 2021 and held it in 4 quarters. The position peaked at $5.21M in Q1 2022. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Grandeur Peak Global Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 72,243 Teladoc Health shares in Q2 2022, an estimated $5.21M.
  • Grandeur Peak Global Advisors first reported a position in Teladoc Health in Q2 2021 and held it in 4 quarters.
  • Grandeur Peak Global Advisors's Teladoc Health position peaked at $5.21M in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Grandeur Peak Global Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.